Learn, Analyse & Invest
only with
only with
+91
Download Orca
Lyka Labs Ltd.
Lyka Labs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹2.06 Cr.
| EX-Date | Purpose |
|---|---|
| 02 06 2021 | Audited Results |
| 04 08 2021 | Quarterly Results |
| 29 10 2021 | Quarterly Results |
| 20 01 2022 | Quarterly Results |
| 20 05 2022 | Audited Results |
| 08 08 2022 | Quarterly Results & Amalgamation |
| 05 09 2022 | Inter alia, to consider and approve: 1. Sale of Land at Dharampur, Valsad and premises situated at Shivshakti Industrial Estate, Andheri East. |
| 09 11 2022 | Quarterly Results |
| 21 01 2023 | Issue Of Warrants & Preferential Issue of shares Inter alia to consider and evaluate proposal for raising of funds by way of issue of equity shares or any other eligible convertible securities, through permissible modes or combination of both, subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company. |
| 07 02 2023 | Quarterly Results |
| 15 03 2023 | Preferential Issue of shares & Issue Of Warrants Inter alia: to allot and issue 20,00,000 Equity Shares and 50,00,000 Warrants convertible into Equity Shares to Ipca Laboratories Limited and to approve draft of Postal Ballot Notice for seeking approval of shareholders for Re-appointment of Mr. Yogesh Shah as an Executive Director. |
| 18 04 2023 | Inter alia: to allot and issue 24,00,000 Equity Shares upon conversion of 24,00,000 Warrants to Ipca Laboratories Limited, part of a ?Promoter Group?. |
| 23 05 2023 | Audited Results |
| 02 08 2023 | Quarterly Results |
| 02 11 2023 | Quarterly Results |
| 08 02 2024 | Quarterly Results |
| 16 04 2024 | Inter alia, to consider and approve :- (1) to allot and issue 2600000 equity shares upon conversion of 2600000 warrants to Ipca Laboratories Limited. |
| 11 10 2024 | Inter-alia, to consider and approve filling of fresh application of scheme of amalgamation of Lyka Exports Limited (Company?s subsidiary) with the Company with the Hon?able National Company Law Tribunal Division Bench, Court - I, Ahmedabad ( the NCLT) in terms of the Order dated 24th September, 2024 passed by the NCLT. |
| 12 11 2024 | Quarterly Results |
| 04 02 2025 | Quarterly Results |
| 26 05 2025 | Audited Results |
| 01 08 2025 | Quarterly Results |
| 29 09 2025 | Inter-alia, to consider and transact following major businesses: 1. To Approve Redemption of unlisted 1,08,570 10% Cumulative Redeemable Preference Shares of Rs.100/- each 2. To approve appointment of Company Secretary and Compliance officer of the Company 3. Any other Business |
| 12 11 2025 | Quarterly Results |
| 29 01 2026 | Quarterly Results |
News
